GLP-1 receptor agonists semaglutide and tirzepatide are associated with reduced risks of dementia, stroke, and mortality in adults with type 2 diabetes and obesity, new data show.

SHOPPING: Take charge of your health with help from Hims, the weight loss program that puts your specific needs front and ...

Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...

Novo Nordisk sees solid Q1 results, major GLP-1 growth potential, and limited downside despite guidance cut and rising risks.

First Kellogg, then Kraft Heinz. Call it the anti-gestalt effect: the whole of a company can be worth less than its sum of ...

Ozempic, a drug known for its physical health benefits, is now gaining recognition for its effectiveness in treating ...

A new study suggests that drugs like Ozempic and Mounjaro may reduce dementia risk. Researchers at the University of Galway ...

Mix one cup of unsweetened Greek yogurt, two tablespoons of chia seeds, and half a cup of mixed berries in a bowl. Let it sit ...

Olympic coach Dane Miller joins Power Athlete Radio to unpack elite training, performance drugs, the science of gut health, and the explosive rise of women’s athletics in a raw, unfiltered ...

As GLP-1-based drugs like semaglutide gain popularity, new insights highlight how gut health, diet, protein, and sleep can ...

Explore "The Ozempic Revolution" by Dr Alexandra Sowa—a guide to weight-loss drugs like Ozempic, their benefits, side effects ...

Tammy Slaton flaunts weight loss, Nick Carter's dance-driven slim-down and more celebrity weight loss revelations of 2025 ...